We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Outgoing FDA Commissioner Scott Gottlieb highlighted plans for drug compounding enforcement among the agency’s drug priorities in his final testimony before House appropriators on Wednesday. Read More
When a drug can be used safely in pediatric populations, it should be made clear in the drug’s “indications and usage” section, the agency says. Read More
The FDA will require a black box label to warn patients of the risk of high blood pressure and an increase in the risk of heart attack and other side effects. Read More
The FDA issued warning letters to two web site operators for selling misbranded and unapproved opioids online, ordering them to immediately cease selling the violative drugs to U.S. customers. Read More
Novartis finds itself in a tough spot after a federal judge refused the company’s request to toss a whistleblower lawsuit that could cost the Swiss-based pharma giant hundreds of millions of dollars. Read More
Increased transparency in the supply chain is the key to lowering insulin prices, patient advocates and health professional told members of the House Energy and Commerce committee on Tuesday. Read More